HIMS Lawsuit Alert! Hims & Hers Faces Class Action Lawsuit After Wegovy Scandal
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Hims & Hers is an American telehealth platform that connects consumers with licensed healthcare professionals and medical treatments. Through the digital platform, consumers can obtain prescription medications, over-the-counter treatments, personal care products, and supplements. The company recently partnered with pharmaceutical giant Novo Nordisk (NVO) to offer its U.S. FDA-approved weight-loss drug Wegovy on the Hims & Hers platform.
The company's claims about its partnership with Novo Nordisk and its future potential are at the heart of the current complaint.
Hims & Hers' Misleading Claims
According to the lawsuit, HIMS and two of its senior officers (the Defendants) repeatedly made false and misleading public statements throughout the Class Period. In particular, they are accused of omitting truthful information about the GLP-1 (glucagon-like peptide-1) injectables it makes available to consumers, and ancillary issues, from SEC filings and related material.
During the Class Period, Hims & Hers announced that it had partnered with Novo Nordisk and that American consumers could start accessing 'NovoCare Pharmacy directly through the Hims & Hers platform, with a bundled offering of all dose strengths of Wegovy and a Hims & Hers membership.' This offering included 24/7 care, continued clinical support, and nutrition guidance, all under one roof. HIMS also noted that patients can access all dose strengths of Wegovy in a high-quality pen, available for self-pay patients (without insurance or government aid).
Furthermore, in a shareholder letter issued on May 5, 2025, Hims expressed excitement over its 'innovative partnerships' that offer consumers greater choice within the weight-loss category. The company also highlighted its long-term collaboration with Novo Nordisk to expand affordable access to proven obesity care. This partnership was touted as a way to strengthen the platform's offerings with Novo Nordisk's innovative pipeline, enabling Hims to serve more customers, expand access to clinically proven treatments, and drive stronger health outcomes.
Finally, in its Q1FY25 quarterly report filed on May 5, Hims & Hers stated that its GLP-1 offerings generated about $230 million in Online segment Revenue, with a significant majority coming from personalized doses.
However, subsequent events (mentioned below) reveal that the defendants failed to disclose that the platform had started engaging in 'deceptive promotion and selling of illegitimate, knockoff versions of Wegovy that put patient safety at risk.'
Plaintiffs' Arguments
The plaintiffs maintain that the defendants deceived investors by lying and withholding critical information about the business practices and prospects during the Class Period. Importantly, the defendants are accused of misleading investors about their illegal practices used to boost Online sales, as well as the potential termination of their contract with Novo Nordisk.
The information became clear before the market opened on June 23, 2025, when Novo Nordisk issued a press release announcing that it was terminating its partnership with Hims & Hers. Novo Nordisk stated that it was ending the collaboration because Hims & Hers had engaged in dishonest promotional tactics and sold illegitimate, copycat versions of Wegovy, thereby putting patient safety at risk.
Moreover, Novo Nordisk explained that HIMS 'failed to adhere to the law, which prohibits mass sales of compounded drugs under the false guise of personalization.' Following the news, HIMS stock collapsed by 34.6% that same day.
To conclude, the defendants misled investors by engaging in deceptive and illegal practices to boost Online sales, which ultimately led to the termination of their lucrative contract with Novo Nordisk. Despite these issues, HIMS stock has surged over 108% so far this year.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
9 minutes ago
- Associated Press
Ambassador Linda Thomas-Greenfield joins Rendeavour board
TATU CITY, Kenya, July 28, 2025 /PRNewswire/ -- Rendeavour, Africa's new city builder, has announced the appointment of Ambassador Linda Thomas-Greenfield to its board of directors. A career diplomat, Ambassador Thomas-Greenfield most recently served as the U.S. Ambassador to the United Nations from 2021-2025. Frank Mosier, Rendeavour's lead American shareholder and Founding Chairman, said the appointment reflects the company's commitment to deepening its engagement with U.S. and African partners. 'Ambassador Linda Thomas-Greenfield is one of the longest-serving champions of Africa in the U.S. government,' he noted, 'and we are honored to have her unparalleled counsel on U.S. and African affairs as we build new cities across the continent.' Backed by American, New Zealand, Norwegian, and British investors, Rendeavour's cities are among the largest construction projects in Africa. These new cities serve as hubs for business, housing, education, and recreation within infrastructure-ready economic zones. The company's current development is valued at more than $5 billion, comprising 200 businesses, schools educating more than 6,000 students, and 15,000 mixed-income homes either occupied or under development. Ambassador Thomas-Greenfield welcomed the opportunity, saying she has followed Rendeavour's new cities in Kenya, Nigeria, Ghana, and the Democratic Republic of the Congo for more than a decade. 'Rendeavour's achievements are extraordinary — from de-risking American and international investments and creating jobs and economic security, to bridging Africa's infrastructure gap — all with private capital,' she said. Rendeavour is the owner and developer of Tatu City, Kenya's first Special Economic Zone (SEZ); Alaro City, a partnership with the Lagos State Government in Nigeria's Lekki Free Zone; Jigna, a mixed-use development in Abuja, Nigeria's capital; and Kiswishi SEZ, the first private SEZ in the Democratic Republic of Congo. In Ghana, Rendeavour is building Appolonia City and King City. Over the past five years, Rendeavour has created more than 50,000 jobs, including through the establishment of East Africa's largest call center, which employs 5,000 young Kenyans serving major American corporate clients. An additional 4,000 call center jobs are confirmed by 2026. Ambassador Thomas-Greenfield has had a storied career in the U.S. government, serving both in Washington, D.C., and across the African continent. Her roles have included U.S. Ambassador to Liberia, Assistant Secretary of State for African Affairs, and Director General of the U.S. Foreign Service. She has also held foreign postings in Switzerland, Pakistan, Kenya, The Gambia, Nigeria, and Jamaica. From 2021 to 2025, she served as the Representative of the United States to the United Nations. In January, Rendeavour also announced the appointments of Graeme Wheeler, former Governor of the Central Bank of New Zealand and Managing Director of the World Bank, and Darrell M. Blocker, former Chief of the Africa Division at the Central Intelligence Agency, to its board of directors. Photo: View original content to download multimedia: SOURCE Rendeavour
Business Insider
29 minutes ago
- Business Insider
Alibaba Cloud founder says early innovation doesn't need top-dollar hires: 'What happened in Silicon Valley is not the winning formula'
True innovation doesn't come from highly paid engineers, but from finding the right people to build the unknown, said the founder of Alibaba's cloud and AI unit. "The only thing you need to do is to get the right person," Wang Jian said in an interview with Bloomberg published Monday. "Not really the expensive person because if it's a new business, if it's true innovation, that basically means talent," he added. Wang, who built Alibaba Cloud in 2009, said American tech giants are "very much focused on the existing success of the business." "And existing — it's average of technology," the computer scientist said. "We have a tremendous opportunity to look at technology nobody knows today." "What happened in Silicon Valley is not the winning formula," Wang said. Wang's comments come after Big Tech companies are paying top dollar to recruit elite AI talent, a trend that's likened to sports franchises competing for superstar athletes like Cristiano Ronaldo. The competition reached another level when Meta recruited Scale's CEO, Alexandr Wang, last month as part of a $14.3 billion deal to take a 49% stake in his company. Then, Sam Altman, the CEO of OpenAI, said Meta had tried to poach his best employees with $100 million signing bonuses. Just weeks ago, Google paid $2.4 billion to hire the CEO and top talent of AI startup Windsurf and license its intellectual property. OpenAI had planned to buy Windsurf for $3 billion, but the deal fell apart. "It's a typical way of doing things," Wang Jian said of Big Tech's hiring strategy. Chasing the same pool of in-demand talent isn't always a winning move, he added. "Whenever everybody knows that these are talents," Wang said, "it's better for you not to get it." "It's really about the vision, you know, where you want to go." Wang and Alibaba did not respond to a request for comment from Business Insider. China's AI race is 'very healthy' competition Wang also said that the rivalry among Chinese AI firms is not cutthroat. No single person or company can sprint forever, he said. But collectively, the ecosystem can still move fast. He pointed to a pattern he's observed: One company surges ahead, then slows. Then another takes the lead. Over time, the first catches up again. "You can have the very fast iteration of the technology because of this competition," he said. "I don't think it's brutal, but I think it's very healthy," he added. China's biggest tech players have focused on open-source AI models, which have code and architecture that are publicly available for anyone to use, modify, or build on. One analyst told Business Insider previously that Chinese firms are prioritizing consolidation to stay competitive. For instance, Tencent has deployed its Hunyuan model and DeepSeek R1 across its massive ecosystem, including WeChat. Baidu has also integrated DeepSeek R1 into its search engine. The country is closing the gap with the US in the AI race. In a Stratechery interview earlier this year, Nvidia's CEO, Jensen Huang, said that China is doing "fantastic" in the AI market, with homegrown models like DeepSeek and Manus emerging as credible challengers to US-built systems. He said China's AI researchers are some of the best in the world, and it's no surprise that US companies like OpenAI and Anthropic are hiring them. "Our competition in China is really intense," Huang said in May at the Computex Taipei tech conference in Taiwan. Huang has also said that the US and China are neck and neck in the AI chip race. "China is right behind us. We're very, very close."
UPI
31 minutes ago
- UPI
Trump, Starmer to meet in Scotland to talk trade, Gaza
President Donald Trump (R) shakes hands with Prime Minister Keir Starmer of Britain at the White House in Washington, D.C., on February 27. The pair are to meet Monday at Trump's Scotland golf course where they are expected to talk trade and the war in Gaza. File Photo by Bonnie Cash/UPI. | License Photo July 28 (UPI) -- U.S. President Donald Trump is set to meet with British Prime Minister Keir Starmer in Scotland on Monday when the Western leaders are expected to discuss cease-fire plans for the Israel-Hamas war in Gaza. Starmer is to travel to Trump's golf course in Turnberry where the American president on Sunday announced a new trade deal with the European Union. According to a statement from 10 Downing Street, Trump and Starmer are to have "wide-ranging" one-on-one talks, including on the implementation of the Economic Prosperity Deal that the pair signed on May 8 and which came into effect last month. Starmer is also expected to discuss with Trump "what more can be done to secure the cease-fire urgently, bring an end to the unspeakable suffering and starvation in Gaza and free the hostages who have been held so cruelly for so long." Since returning to the White House in January, Trump has sought a cease-fire and hostage-release deal in the war in the Palestinian enclave of Gaza between Iran-poxy militia Hamas and Israel, but has repeatedly been met with obstacles. On Thursday, Israel and the United States recalled their negotiators, ending talks with Hamas that had initially sparked optimism that a deal could be reached. The Trump administration has blamed Hamas for the breakdown, with Steve Witkoff, Trump's special envoy to the Middle East, stating the Iran-backed militia's latest response "clearly shows a lack of desire to reach a cease-fire in Gaza." "It's a shame Hamas has acted in this selfish way," he said in a statement. The Trump-Starmer meeting comes amid a deteriorating situation in Gaza where aid agencies are warning of starvation. Israel has announced a so-called tactical pause to fighting in specific areas to allow the delivery of aid between the hours of 10 a.m. and 8 p.m., local time, on Sunday. The announcement came as the Middle Eastern country is coming under mounting international pressure over its war in Gaza and its restrictions on aid entering the territory. According to the Save the Children charity, 133 people, including 87 children, have already died from malnutrition and starvation. Britain is among 30 nations that are calling for the war in Gaza to end, describing Israel's aid delivery model as "dangerous, fuels instability and deprives Gazans of human dignity." "We condemn the drip-feeding of aid and the inhumane killing of civilians, including children, seeking to meet their most basic needs of water and food," the nations said in the joint statement, which calls on Israel to lift the restrictions on the flow of aid. "The Israeli government's denial of essential humanitarian assistance to the civilian population is unacceptable. Israel must comply with its obligations under international humanitarian law." Britain, France and Germany separately over the weekend issued a statement calling for Israel and Hamas to end the conflict "by reaching an immediate cease-fire." Trump and Starmer are also expected to discuss the war in Ukraine. After the meeting, they will have a private engagement in Aberdeen, 10 Downing Street said. The meeting also comes ahead of Trump being received for a State Visit hosted by King Charles III at Windsor Castle from Sept. 17 to 19. It will be Trump's second State Visit after a previous trip in 2019 where he was hosted by the late Queen Elizabeth II.
